US Stock MarketDetailed Quotes

AN2 Therapeutics (ANTX)

Watchlist

4.490
-0.260-5.47%

Trading May 18 12:17 ET

161.71MMarket Cap-4.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AN2 Therapeutics (ANTX) Balance Sheet

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Assets

Current assets

Cash, cash equivalents and short term investments

27.18%85.29M

-30.64%58M

-33.72%61.92M

-39.82%62.92M

-41.28%67.06M

-22.07%83.62M

-24.55%93.43M

9.74%104.54M

-Cash and cash equivalents

167.64%53.49M

-6.60%19.94M

-46.27%18M

-31.94%18.22M

-19.07%19.99M

36.45%21.35M

2.72%33.5M

-34.41%26.77M

-Short-term investments

-32.45%31.8M

-38.88%38.06M

-26.71%43.92M

-42.53%44.7M

-47.41%47.08M

-32.06%62.27M

-34.30%59.92M

42.84%77.77M

Other current assets

-11.84%2.2M

-26.78%1.94M

-50.86%2.1M

59.01%4.61M

18.83%2.5M

-17.68%2.64M

64.53%4.26M

-1.70%2.9M

Total current assets

25.78%87.49M

-30.52%59.94M

-34.47%64.02M

-37.15%67.52M

-40.20%69.56M

-21.94%86.26M

-22.72%97.69M

9.40%107.44M

Non current assets

Investments and advances

--0

-59.91%2.01M

--3.22M

--8.3M

194.06%11.48M

-81.54%5.02M

--0

Other non current assets

----

-70.85%304K

-22.91%804K

----

44.86%1.04M

Total non current assets

--0

-65.44%2.01M

--3.22M

695.88%8.3M

138.20%11.78M

-79.37%5.83M

--0

44.86%1.04M

Total assets

7.56%87.49M

-32.73%61.95M

-31.17%67.24M

-30.10%75.83M

-32.92%81.34M

-33.63%92.09M

-36.49%97.69M

9.66%108.48M

Liabilities

Current liabilities

Payables

-14.90%2.62M

-8.92%3.02M

30.10%2.23M

12.10%2.11M

26.30%3.07M

23.95%3.32M

-64.92%1.71M

-39.80%1.89M

-accounts payable

-14.90%2.62M

-8.92%3.02M

30.10%2.23M

12.10%2.11M

26.30%3.07M

23.95%3.32M

-64.92%1.71M

-39.80%1.89M

Current accrued expenses

-56.29%1.77M

-53.93%2.05M

-45.03%2.71M

-49.44%2.95M

-41.52%4.04M

-33.33%4.45M

-27.53%4.92M

-9.31%5.84M

Other current liabilities

53.66%567K

55.37%1.23M

-85.65%183K

28.26%717K

14.95%369K

18.41%791K

30.64%1.28M

18,533.33%559K

Current liabilities

-30.60%5.56M

-14.83%8.72M

-31.54%6.86M

-31.05%6.98M

-24.84%8.01M

-27.10%10.24M

-32.50%10.02M

-9.26%10.13M

Non current liabilities

Other non current liabilities

--170K

----

Total non current liabilities

--170K

--0

Total liabilities

-28.48%5.73M

-13.17%8.89M

-31.54%6.86M

-31.05%6.98M

-24.84%8.01M

-27.10%10.24M

-32.50%10.02M

-9.27%10.13M

Shareholders'equity

Share capital

--0

-common stock

--0

-Preferred stock

--0

Retained earnings

-15.97%-250.98M

-17.09%-240.95M

-17.14%-232.24M

-20.15%-222.89M

-26.51%-216.43M

-33.23%-205.78M

-44.12%-198.25M

-53.50%-185.51M

Paid-in capital

14.86%332.74M

2.21%293.95M

2.36%292.55M

2.75%291.7M

2.87%289.71M

3.12%287.59M

3.31%285.81M

36.01%283.89M

Gains losses not affecting retained earnings

-110.42%-5K

83.87%57K

-42.86%64K

192.59%25K

-9.43%48K

-88.73%31K

191.80%112K

77.31%-27K

Total stockholders'equity

11.50%81.76M

-35.17%53.06M

-31.13%60.38M

-30.01%68.84M

-33.70%73.33M

-34.36%81.85M

-36.91%87.67M

12.07%98.35M

Total equity

11.50%81.76M

-35.17%53.06M

-31.13%60.38M

-30.01%68.84M

-33.70%73.33M

-34.36%81.85M

-36.91%87.67M

12.07%98.35M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments	27.18%85.29M	-30.64%58M	-30.64%58M	-33.72%61.92M	-39.82%62.92M	-41.28%67.06M	-22.07%83.62M	-22.07%83.62M	-24.55%93.43M	9.74%104.54M
-Cash and cash equivalents	167.64%53.49M	-6.60%19.94M	-6.60%19.94M	-46.27%18M	-31.94%18.22M	-19.07%19.99M	36.45%21.35M	36.45%21.35M	2.72%33.5M	-34.41%26.77M
-Short-term investments	-32.45%31.8M	-38.88%38.06M	-38.88%38.06M	-26.71%43.92M	-42.53%44.7M	-47.41%47.08M	-32.06%62.27M	-32.06%62.27M	-34.30%59.92M	42.84%77.77M
Other current assets	-11.84%2.2M	-26.78%1.94M	-26.78%1.94M	-50.86%2.1M	59.01%4.61M	18.83%2.5M	-17.68%2.64M	-17.68%2.64M	64.53%4.26M	-1.70%2.9M
Total current assets	25.78%87.49M	-30.52%59.94M	-30.52%59.94M	-34.47%64.02M	-37.15%67.52M	-40.20%69.56M	-21.94%86.26M	-21.94%86.26M	-22.72%97.69M	9.40%107.44M
Non current assets
Investments and advances	--0	-59.91%2.01M	-59.91%2.01M	--3.22M	--8.3M	194.06%11.48M	-81.54%5.02M	-81.54%5.02M	--0	--0
Other non current assets	----	----	----	----	----	-70.85%304K	-22.91%804K	-22.91%804K	----	44.86%1.04M
Total non current assets	--0	-65.44%2.01M	-65.44%2.01M	--3.22M	695.88%8.3M	138.20%11.78M	-79.37%5.83M	-79.37%5.83M	--0	44.86%1.04M
Total assets	7.56%87.49M	-32.73%61.95M	-32.73%61.95M	-31.17%67.24M	-30.10%75.83M	-32.92%81.34M	-33.63%92.09M	-33.63%92.09M	-36.49%97.69M	9.66%108.48M
Liabilities
Current liabilities
Payables	-14.90%2.62M	-8.92%3.02M	-8.92%3.02M	30.10%2.23M	12.10%2.11M	26.30%3.07M	23.95%3.32M	23.95%3.32M	-64.92%1.71M	-39.80%1.89M
-accounts payable	-14.90%2.62M	-8.92%3.02M	-8.92%3.02M	30.10%2.23M	12.10%2.11M	26.30%3.07M	23.95%3.32M	23.95%3.32M	-64.92%1.71M	-39.80%1.89M
Current accrued expenses	-56.29%1.77M	-53.93%2.05M	-53.93%2.05M	-45.03%2.71M	-49.44%2.95M	-41.52%4.04M	-33.33%4.45M	-33.33%4.45M	-27.53%4.92M	-9.31%5.84M
Other current liabilities	53.66%567K	55.37%1.23M	55.37%1.23M	-85.65%183K	28.26%717K	14.95%369K	18.41%791K	18.41%791K	30.64%1.28M	18,533.33%559K
Current liabilities	-30.60%5.56M	-14.83%8.72M	-14.83%8.72M	-31.54%6.86M	-31.05%6.98M	-24.84%8.01M	-27.10%10.24M	-27.10%10.24M	-32.50%10.02M	-9.26%10.13M
Non current liabilities
Other non current liabilities	--170K	--170K	--170K	----	----	----	----	----	----	----
Total non current liabilities	--170K	--170K	--170K	--0	--0	--0	--0	--0	--0	--0
Total liabilities	-28.48%5.73M	-13.17%8.89M	-13.17%8.89M	-31.54%6.86M	-31.05%6.98M	-24.84%8.01M	-27.10%10.24M	-27.10%10.24M	-32.50%10.02M	-9.27%10.13M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-15.97%-250.98M	-17.09%-240.95M	-17.09%-240.95M	-17.14%-232.24M	-20.15%-222.89M	-26.51%-216.43M	-33.23%-205.78M	-33.23%-205.78M	-44.12%-198.25M	-53.50%-185.51M
Paid-in capital	14.86%332.74M	2.21%293.95M	2.21%293.95M	2.36%292.55M	2.75%291.7M	2.87%289.71M	3.12%287.59M	3.12%287.59M	3.31%285.81M	36.01%283.89M
Gains losses not affecting retained earnings	-110.42%-5K	83.87%57K	83.87%57K	-42.86%64K	192.59%25K	-9.43%48K	-88.73%31K	-88.73%31K	191.80%112K	77.31%-27K
Total stockholders'equity	11.50%81.76M	-35.17%53.06M	-35.17%53.06M	-31.13%60.38M	-30.01%68.84M	-33.70%73.33M	-34.36%81.85M	-34.36%81.85M	-36.91%87.67M	12.07%98.35M
Total equity	11.50%81.76M	-35.17%53.06M	-35.17%53.06M	-31.13%60.38M	-30.01%68.84M	-33.70%73.33M	-34.36%81.85M	-34.36%81.85M	-36.91%87.67M	12.07%98.35M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm